Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site rash, Vaccination site warmth
Clinical narrative: She had a little reaction, little redness, and soreness and  warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.; Red rash 7 cm X 13 cm occurring at the injection site; Tenderness at the injection site; Redness at the injection site/red at the injection site; Soreness at the at the injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (She had a little reaction, little redness, and soreness and  warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.), VACCINATION SITE ERYTHEMA (Redness at the injection site/red at the injection site), VACCINATION SITE PAIN (Soreness at the at the injection site), VACCINATION SITE RASH (Red rash 7 cm X 13 cm occurring at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.   Concurrent medical conditions included Allergy to insect sting (Sensitive to mosquito and flea bites).  On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness at the injection site/red at the injection site) and VACCINATION SITE PAIN (Soreness at the at the injection site). On 28-Jan-2021, the patient experienced VACCINATION SITE WARMTH (She had a little reaction, little redness, and soreness and  warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.), VACCINATION SITE RASH (Red rash 7 cm X 13 cm occurring at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site). On 30-Jan-2021, VACCINATION SITE PAIN (Soreness at the at the injection site) and VACCINATION SITE PAIN (Tenderness at the injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (She had a little reaction, little redness, and soreness and  warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site.) had not resolved and VACCINATION SITE ERYTHEMA (Redness at the injection site/red at the injection site) and VACCINATION SITE RASH (Red rash 7 cm X 13 cm occurring at the injection site) was resolving.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient had a little reaction, little redness and soreness went away after a few days and 9 days later (28-Jan-2021) she had COVID arm: warmth, tenderness, (2 days) red rash 7 cm X 13 cm occurring at the injection site which had faded to a pink at the time of this report.  Treatment information were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.